Newly-released cell lysis & disruption market analysis report by Transparency Market Research shows that global sales of the Market in 2021 were held at US$ 4.1 Bn. With 12.9%, the projected market growth during 2022 - 2032 is expected to be higher than the historical growth. The Reagent-Based Cell Lysis & Disruption Technique is expected to be the highest revenue-generating segment, accounting for a CAGR of nearly 13.6% during 2022 – 2032.
As per the cell lysis & disruption industry research by Transparency Market Research - a market research and competitive intelligence provider, historically, from 2017 to 2021, the market value of the Market industry increased at around 13.9% CAGR, wherein, countries such as the U.S., UK, China, Japan, and South Korea held a significant share in the global market.
Cell lysis and disruption is a technique for releasing intercellular materials such as deoxyribonucleic acid (DNA), ribonucleic acid (RNA), and proteins from a cell by destroying the cell membrane. These techniques are crucial for immunoassays used in point-of-care diagnostics, as well as downstream processes including protein extraction for researching protein function and structure, drug screening, and mRNA transcriptome determination.
The adoption of ultrasonic homogenization, rising demand for chelating agent testing using mammalian cells, rising demand for sodium dodecyl sulfate (SDS) to provide cell lysis on the order of seconds, and rising demand for the osmotic shock technique using bacterial cells are the factors expected to propel the market for Cell Lysis & Disruption for the period 2022-2032.
The severe respiratory implications of the COVID-19 pandemic have created an urgent demand for new medicines, which has resulted in an increase in pharmacological discoveries, which has benefited the cell lysis market. In May 2020, the Department of Biotechnology (DBT) in India launched a project to sequence 1,000 SARS-CoV-2 genomes from samples in order to better understand the virus that causes COVID-19.
The samples were collected across India in order to research the virus's evolving mutations and how they affect the disease's symptoms. As a result, all of this increased research has used a variety of processes, raising the demand for systems and reagents. As a result, the widespread use of cell lysis and disruption technologies in downstream processing for the production of biotherapeutics and other animal-based recombinant products increases overall market growth.
Because retrieval and purification of biopharmaceuticals require cell lysis and disruption, the expansion of the biopharmaceutical industry would open up new growth opportunities for the market. Furthermore, the market is likely to be driven by the adoption of biotech processes in the bio-services industries agricultural, and, pharmaceutical, as cell lysis plays a significant role in the bioprocess.
Demand for effective tumor tissue dissociation equipment has prompted the development of new microfluidics-based devices. Microfluidic devices have been proven effective in dissociating tumor tissues into single cells, resulting in improved cell recovery in terms of number and purity.
Over the forecast period, APAC is expected to have the highest CAGR. This expansion might be attributed to significant firms' growing interest in profiting from rising markets in the APAC region. The rapid adoption of technology advancements, as well as a legislative environment that encourages innovation, are influencing the market growth in Asian countries such as Japan and China. Furthermore, the rapidly expanding field of customized cancer medicine in Asian countries is expected to boost market growth.
North America had the highest revenue share, followed closely by Europe. The market dominance of the United States and Canada is due to the presence of government initiatives that fund molecular biology research, precision medicine, and cancer research. High private and public investments in target therapies and novel drug discovery for a variety of challenging and uncommon diseases are expected to fuel demand even more.
The market in the U.S. is projected to reach a valuation of US$ 6.1 Bn by 2032. Growing with a CAGR of 13.9% during 2022 – 2032, the market is expected to register an absolute dollar opportunity of US$ 4.4 Bn.
The market in the U.K. is expected to reach US$ 617.2 Bn by 2032. With a CAGR of 13.5% during the forecast period, the market is expected to gross US$ 442 Mn absolute dollar opportunity.
The market for reagent-based cell lysis & disruption will generate the highest revenue throughout the analysis period. These procedures are gentle and ideal for laboratory samples because they do not damage the biological activity of the final products. Because of the aforementioned characteristics, they are an excellent choice for laboratory use, resulting in their market share supremacy over the projection period.
In the product type segment, the reagents and consumables segment had the highest revenue share. The reagents and consumables sub-segment was dominated by enzymes, which are expected to grow at a significant rate over the projection period.
Several kits and enzymes are used for plant, yeast, bacterial, and mammalian samples due to enzyme specificity. These enzymes are accessible in a number of commercial forms. Millipore Sigma, Alfa Aesar, Pierce Biotechnology Inc., MP Biochemicals LLC, and Promega Corp. are some of the major names.
Throughout the projected period, the mammalian cells sector is expected to maintain its dominance. This is due to the widespread use of mammalian culture systems in the bioproduction of viral vaccines, therapeutic proteins, and other recombinant products.
Furthermore, the use of 3D mammalian culture systems for stem cell and cancer research is expected to drive segment expansion. Because reagent performance varies depending on the type of cell employed, significant players have created reagents that are particular to mammalian cells.
The market is moderately competitive and includes both domestic and international businesses. Thermo Fisher Scientific Inc., Merck KGaA, F. Hoffmann-La Roche Ltd, Qiagen NV, and Becton, Dickinson and Company are just a few of the major players. These businesses are concentrating on new product development as well as acquisitions and collaborations in order to strengthen their market positions.
Few small to mid-sized companies are joining the market as a result of improvements in the pharmaceutical and biotechnology sectors, and it is expected that these companies will hold a significant proportion of the market research in the future. In addition, due to new product introductions in this industry, competition is expanding.
Some of the recent developments of key players in the Market are as follows:
Similarly, recent developments related to companies offering Markets have been tracked by the team at Transparency Market Research, which is available in the full report.
By Technique
By Product Type
By Cell Type
By Application
By Region
|
Attribute |
Details |
|
Global Cell & Disruption Market (2022) |
US$ 4.6 Bn |
|
Global Cell & Disruption Market (2032) |
US$ 15.5 Bn |
|
Global Cell & Disruption Market CAGR (2022 – 2032) |
12.9% |
|
U.S. Cell & Disruption Market CAGR (2022 – 2032) |
13.9% |
|
Key Companies Profiled |
|
The global market for Cell Lysis & Disruption is worth more than US$ 4.6 Bn at present.
The value of the global Market is projected to increase at a CAGR of around 12.9% during 2022 – 2032.
The value of the global market for Cell Lysis & Disruption increased at a CAGR of around 11.1% during 2017 – 2021.
With a CAGR of 11.3% historically, the Reagent-Based Technique segment dominated the Cell Lysis & Disruption industry.
The top 5 countries driving demand for Cell Lysis & Disruption business are the U.S., U.K., China, Japan, and South Korea.
The UK market for Cell Lysis & Disruption is projected to expand at a CAGR of around 13.5% during 2022 – 2032.
While the market in South Korea is expected to grow at nearly 13.1%, the market in Japan is projected to register a CAGR of nearly 13.5% during 2022 - 2032.
1. Executive Summary
1.1. Global Market Outlook
1.2. Summary of Statistics
1.3. Key Market Characteristics & Attributes
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage
2.2. Market Definition
3. Market Risks and Trends Assessment
3.1. Risk Assessment
3.1.1. COVID-19 Crisis and Impact on Cell Lysis & Disruption
3.1.2. COVID-19 Impact Benchmark with Previous Crisis
3.1.3. Impact on Market Value (US$ Bn)
3.1.4. Assessment by Key Countries
3.1.5. Assessment by Key Market Segments
3.1.6. Action Points and Recommendation for Suppliers
3.2. Key Trends Impacting the Market
3.3. Formulation and Product Development Trends
4. Market Background
4.1. Cell Lysis & Disruption Market, by Key Countries
4.2. Cell Lysis & Disruption Market Opportunity Assessment (US$ Bn)
4.2.1. Total Available Market
4.2.2. Serviceable Addressable Market
4.2.3. Serviceable Obtainable Market
4.3. Market Scenario Forecast
4.3.1. Demand in optimistic Scenario
4.3.2. Demand in Likely Scenario
4.3.3. Demand in Conservative Scenario
4.4. Investment Feasibility Analysis
4.4.1. Investment in Established Markets
4.4.1.1. In Short Term
4.4.1.2. In Long Term
4.4.2. Investment in Emerging Markets
4.4.2.1. In Short Term
4.4.2.2. In Long Term
4.5. Forecast Factors - Relevance & Impact
4.5.1. Top Companies Historical Growth
4.5.2. Growth in Automation, By Country
4.5.3. Cell Lysis & Disruption Adoption Rate, By Country
4.6. Market Dynamics
4.6.1. Market Driving Factors and Impact Assessment
4.6.2. Prominent Market Challenges and Impact Assessment
4.6.3. Cell Lysis & Disruption Market Opportunities
4.6.4. Prominent Trends in the Global Market & Their Impact Assessment
5. Key Success Factors
5.1. Manufacturers’ Focus on Low Penetration High Growth Markets
5.2. Banking on with Segments High Incremental Opportunity
5.3. Peer Benchmarking
6. Global Cell Lysis & Disruption Market Demand Analysis 2017-2021 and Forecast, 2022-2032
6.1. Historical Market Analysis, 2017-2021
6.2. Current and Future Market Projections, 2022-2032
6.3. Y-o-Y Growth Trend Analysis
7. Global Cell Lysis & Disruption Market Value Analysis 2017-2021 and Forecast, 2022-2032
7.1. Historical Market Value (US$ Bn) Analysis, 2017-2021
7.2. Current and Future Market Value (US$ Bn) Projections, 2022-2032
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Cell Lysis & Disruption Market Analysis 2017-2021 and Forecast 2022-2032, By Technique
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Bn) Analysis By Technique, 2017-2021
8.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Technique, 2022-2032
8.3.1. Reagent-Based
8.3.1.1. Detergent
8.3.1.2. Enzymatic
8.3.2. Physical Disruption
8.3.2.1. Mechanical Homogenization
8.3.2.2. Ultrasonic Homogenization
8.3.2.3. Pressure Homogenization
8.3.2.4. Temperature Treatments
8.4. Market Attractiveness Analysis By Technique
9. Global Cell Lysis & Disruption Market Analysis 2017-2021 and Forecast 2022-2032, By Product Type
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Bn) Analysis By Product Type, 2017-2021
9.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Product Type, 2022-2032
9.3.1. Instruments
9.3.2. Reagents & Consumables
9.4. Market Attractiveness Analysis By Product Type
10. Global Cell Lysis & Disruption Market Analysis 2017-2021 and Forecast 2022-2032, By Cell Type
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Bn) Analysis By Cell Type, 2017-2021
10.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Cell Type, 2022-2032
10.3.1. Mammalian Cells
10.3.2. Bacterial Cells
10.3.3. Yeast/Algae/Fungi
10.3.4. Plant Cells
10.4. Market Attractiveness Analysis By Cell Type
11. Global Cell Lysis & Disruption Market Analysis 2017-2021 and Forecast 2022-2032, By Application
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Bn) Analysis By Application, 2017-2021
11.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Application, 2022-2032
11.3.1. Protein Isolation
11.3.2. Downstream Processing
11.3.3. Cell organelle Isolation
11.3.4. Nucleic acid Isolation
11.4. Market Attractiveness Analysis By Application
12. Global Cell Lysis & Disruption Market Analysis 2017-2021 and Forecast 2022-2032, By Region
12.1. Introduction
12.2. Historical Market Size (US$ Bn) Analysis By Region, 2017-2021
12.3. Current Market Size (US$ Bn) & Analysis and Forecast By Region, 2022-2032
12.3.1. North America
12.3.2. Latin America
12.3.3. Europe
12.3.4. APAC
12.3.5. Middle East and Africa (MEA)
12.4. Market Attractiveness Analysis By Region
13. North America Cell Lysis & Disruption Market Analysis 2017-2021 and Forecast 2022-2032
13.1. Introduction
13.2. Pricing Analysis
13.3. Historical Market Value (US$ Bn) Trend Analysis By Market Taxonomy, 2017-2021
13.4. Market Value (US$ Bn) & Forecast By Market Taxonomy, 2022-2032
13.4.1. By Country
13.4.1.1. U.S.
13.4.1.2. Canada
13.4.1.3. Rest of North America
13.4.2. By Technique
13.4.3. By Product Type
13.4.4. By Application
13.4.5. By Cell Type
13.5. Market Attractiveness Analysis
13.5.1. By Country
13.5.2. By Technique
13.5.3. By Product Type
13.5.4. By Application
13.5.5. By Cell Type
14. Latin America Cell Lysis & Disruption Market Analysis 2017-2021 and Forecast 2022-2032
14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Value (US$ Bn) Trend Analysis By Market Taxonomy, 2017-2021
14.4. Market Value (US$ Bn) & Forecast By Market Taxonomy, 2022-2032
14.4.1. By Country
14.4.1.1. Brazil
14.4.1.2. Mexico
14.4.1.3. Rest of Latin America
14.4.2. By Technique
14.4.3. By Product Type
14.4.4. By Application
14.4.5. By Cell Type
14.5. Market Attractiveness Analysis
14.5.1. By Country
14.5.2. By Technique
14.5.3. By Product Type
14.5.4. By Application
14.5.5. By Cell Type
15. Europe Cell Lysis & Disruption Market Analysis 2017-2021 and Forecast 2022-2032
15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Value (US$ Bn) Trend Analysis By Market Taxonomy, 2017-2021
15.4. Market Value (US$ Bn) & Forecast By Market Taxonomy, 2022-2032
15.4.1. By Country
15.4.1.1. Germany
15.4.1.2. France
15.4.1.3. U.K.
15.4.1.4. Italy
15.4.1.5. Spain
15.4.1.6. Netherlands
15.4.1.7. Rest of Europe
15.4.2. By Technique
15.4.3. By Product Type
15.4.4. By Application
15.4.5. By Cell Type
15.5. Market Attractiveness Analysis
15.5.1. By Country
15.5.2. By Technique
15.5.3. By Product Type
15.5.4. By Application
15.5.5. By Cell Type
16. APAC Cell Lysis & Disruption Market Analysis 2017-2021 and Forecast 2022-2032
16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Value (US$ Bn) Trend Analysis By Market Taxonomy, 2017-2021
16.4. Market Value (US$ Bn) & Forecast By Market Taxonomy, 2022-2032
16.4.1. By Country
16.4.1.1. China
16.4.1.2. Japan
16.4.1.3. South Korea
16.4.1.4. Rest of APAC
16.4.2. By Technique
16.4.3. By Product Type
16.4.4. By Application
16.4.5. By Cell Type
16.5. Market Attractiveness Analysis
16.5.1. By Country
16.5.2. By Technique
16.5.3. By Product Type
16.5.4. By Application
16.5.5. By Cell Type
17. Middle East and Africa Cell Lysis & Disruption Market Analysis 2017-2021 and Forecast 2022-2032
17.1. Introduction
17.2. Pricing Analysis
17.3. Historical Market Value (US$ Bn) Trend Analysis By Market Taxonomy, 2017-2021
17.4. Market Value (US$ Bn) & Forecast By Market Taxonomy, 2022-2032
17.4.1. By Country
17.4.1.1. Saudi Arabia
17.4.1.2. South Africa
17.4.1.3. UAE
17.4.1.4. Rest of Middle East and Africa
17.4.2. By Technique
17.4.3. By Product Type
17.4.4. By Application
17.4.5. By Cell Type
17.5. Market Attractiveness Analysis
17.5.1. By Country
17.5.2. By Technique
17.5.3. By Product Type
17.5.4. By Application
17.5.5. By Cell Type
18. Key Countries Cell Lysis & Disruption Market Analysis 2017-2021 and Forecast 2022-2032
18.1. Introduction
18.1.1. Market Value Proportion Analysis, By Key Countries
18.1.2. Global Vs. Country Growth Comparison
18.2. US Cell Lysis & Disruption Market Analysis
18.2.1. Value Proportion Analysis by Market Taxonomy
18.2.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
18.2.2.1. By Technique
18.2.2.2. By Product Type
18.2.2.3. By Application
18.2.2.4. By Cell Type
18.3. Canada Cell Lysis & Disruption Market Analysis
18.3.1. Value Proportion Analysis by Market Taxonomy
18.3.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
18.3.2.1. By Technique
18.3.2.2. By Product Type
18.3.2.3. By Application
18.3.2.4. By Cell Type
18.4. Mexico Cell Lysis & Disruption Market Analysis
18.4.1. Value Proportion Analysis by Market Taxonomy
18.4.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
18.4.2.1. By Technique
18.4.2.2. By Product Type
18.4.2.3. By Application
18.4.2.4. By Cell Type
18.5. Brazil Cell Lysis & Disruption Market Analysis
18.5.1. Value Proportion Analysis by Market Taxonomy
18.5.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
18.5.2.1. By Technique
18.5.2.2. By Product Type
18.5.2.3. By Application
18.5.2.4. By Cell Type
18.6. Germany Cell Lysis & Disruption Market Analysis
18.6.1. Value Proportion Analysis by Market Taxonomy
18.6.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
18.6.2.1. By Technique
18.6.2.2. By Product Type
18.6.2.3. By Application
18.6.2.4. By Cell Type
18.7. France Cell Lysis & Disruption Market Analysis
18.7.1. Value Proportion Analysis by Market Taxonomy
18.7.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
18.7.2.1. By Technique
18.7.2.2. By Product Type
18.7.2.3. By Application
18.7.2.4. By Cell Type
18.8. Italy Cell Lysis & Disruption Market Analysis
18.8.1. Value Proportion Analysis by Market Taxonomy
18.8.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
18.8.2.1. By Technique
18.8.2.2. By Product Type
18.8.2.3. By Application
18.8.2.4. By Cell Type
18.9. Spain Cell Lysis & Disruption Market Analysis
18.9.1. Value Proportion Analysis by Market Taxonomy
18.9.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
18.9.2.1. By Technique
18.9.2.2. By Product Type
18.9.2.3. By Application
18.9.2.4. By Cell Type
18.10. UK Cell Lysis & Disruption Market Analysis
18.10.1. Value Proportion Analysis by Market Taxonomy
18.10.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
18.10.2.1. By Technique
18.10.2.2. By Product Type
18.10.2.3. By Application
18.10.2.4. By Cell Type
18.11. Netherlands Cell Lysis & Disruption Market Analysis
18.11.1. Value Proportion Analysis by Market Taxonomy
18.11.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
18.11.2.1. By Technique
18.11.2.2. By Product Type
18.11.2.3. By Application
18.11.2.4. By Cell Type
18.12. China Cell Lysis & Disruption Market Analysis
18.12.1. Value Proportion Analysis by Market Taxonomy
18.12.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
18.12.2.1. By Technique
18.12.2.2. By Product Type
18.12.2.3. By Application
18.12.2.4. By Cell Type
18.13. Japan Cell Lysis & Disruption Market Analysis
18.13.1. Value Proportion Analysis by Market Taxonomy
18.13.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
18.13.2.1. By Technique
18.13.2.2. By Product Type
18.13.2.3. By Application
18.13.2.4. By Cell Type
18.14. South Korea Cell Lysis & Disruption Market Analysis
18.14.1. Value Proportion Analysis by Market Taxonomy
18.14.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
18.14.2.1. By Technique
18.14.2.2. By Product Type
18.14.2.3. By Application
18.14.2.4. By Cell Type
18.15. Saudi Arabia Cell Lysis & Disruption Market Analysis
18.15.1. Value Proportion Analysis by Market Taxonomy
18.15.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
18.15.2.1. By Technique
18.15.2.2. By Product Type
18.15.2.3. By Application
18.15.2.4. By Cell Type
18.16. South Africa Cell Lysis & Disruption Market Analysis
18.16.1. Value Proportion Analysis by Market Taxonomy
18.16.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
18.16.2.1. By Technique
18.16.2.2. By Product Type
18.16.2.3. By Application
18.16.2.4. By Cell Type
18.17. UAE Cell Lysis & Disruption Market Analysis
18.17.1. Value Proportion Analysis by Market Taxonomy
18.17.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
18.17.2.1. By Technique
18.17.2.2. By Product Type
18.17.2.3. By Application
18.17.2.4. By Cell Type
18.17.3. Competition Landscape and Player Concentration in the Country
19. Market Structure Analysis
19.1. Market Analysis by Tier of Companies
19.2. Market Concentration
19.3. Market Share Analysis of Top Players
19.4. Market Presence Analysis
19.4.1. By Regional footprint of Players
19.4.2. Product footprint by Players
20. Competition Analysis
20.1. Competition Dashboard
20.2. Competition Benchmarking
20.3. Competition Deep Dive
20.3.1. Thermo Fisher Scientific, Inc.
20.3.1.1. Overview
20.3.1.2. Product Portfolio
20.3.1.3. Sales Footprint
20.3.1.4. Strategy Overview
20.3.2. Merck KGaA
20.3.2.1. Overview
20.3.2.2. Product Portfolio
20.3.2.3. Sales Footprint
20.3.2.4. Strategy Overview
20.3.3. F. Hoffmann-La Roche Ltd.
20.3.3.1. Overview
20.3.3.2. Product Portfolio
20.3.3.3. Sales Footprint
20.3.3.4. Strategy Overview
20.3.4. Qiagen NV
20.3.4.1. Overview
20.3.4.2. Product Portfolio
20.3.4.3. Sales Footprint
20.3.4.4. Strategy Overview
20.3.5. Becton Dickinson & Company (BD)
20.3.5.1. Overview
20.3.5.2. Product Portfolio
20.3.5.3. Sales Footprint
20.3.5.4. Strategy Overview
20.3.6. Danaher Corp.
20.3.6.1. Overview
20.3.6.2. Product Portfolio
20.3.6.3. Sales Footprint
20.3.6.4. Strategy Overview
20.3.7. Bio-Rad Laboratories, Inc.
20.3.7.1. Overview
20.3.7.2. Product Portfolio
20.3.7.3. Sales Footprint
20.3.7.4. Strategy Overview
20.3.8. Miltenyi Biotec GmbH
20.3.8.1. Overview
20.3.8.2. Product Portfolio
20.3.8.3. Sales Footprint
20.3.8.4. Strategy Overview
20.3.9. Claremont BioSolutions, LLC
20.3.9.1. Overview
20.3.9.2. Product Portfolio
20.3.9.3. Sales Footprint
20.3.9.4. Strategy Overview
20.3.10. Microfluidics International Corp.
20.3.10.1. Overview
20.3.10.2. Product Portfolio
20.3.10.3. Sales Footprint
20.3.10.4. Strategy Overview
20.3.11. Parr Instrument Company
20.3.11.1. Overview
20.3.11.2. Product Portfolio
20.3.11.3. Sales Footprint
20.3.11.4. Strategy Overview
20.3.12. BioVision, Inc.
20.3.12.1. Overview
20.3.12.2. Product Portfolio
20.3.12.3. Sales Footprint
20.3.12.4. Strategy Overview
20.3.13. Covaris, Inc.
20.3.13.1. Overview
20.3.13.2. Product Portfolio
20.3.13.3. Sales Footprint
20.3.13.4. Strategy Overview
20.3.14. Qsonica LLC
20.3.14.1. Overview
20.3.14.2. Product Portfolio
20.3.14.3. Sales Footprint
20.3.14.4. Strategy Overview
21. Assumptions and Acronyms Used
22. Research Methodology
List of Tables
Table 1: Global Cell Lysis & Disruption Market Value (US$ Bn),By Technique, 2017 – 2021
Table 2: Global Cell Lysis & Disruption Market Value (US$ Bn),By Technique, 2022 – 2032
Table 3: Global Cell Lysis & Disruption Market Value (US$ Bn), By Product Type, 2017 – 2021
Table 4: Global Cell Lysis & Disruption Market Value (US$ Bn), By Product Type, 2022 – 2032
Table 5: Global Cell Lysis & Disruption Market Value (US$ Bn), By Cell Type, 2017 – 2021
Table 6: Global Cell Lysis & Disruption Market Value (US$ Bn), By Cell Type, 2022 – 2032
Table 7: Global Cell Lysis & Disruption Market Value (US$ Bn), By Application, 2017 – 2021
Table 8: Global Cell Lysis & Disruption Market Value (US$ Bn), By Application, 2022 – 2032
Table 9: Global Cell Lysis & Disruption Market, By Region, 2017 – 2021
Table 10: Global Cell Lysis & Disruption Market, By Region, 2022 – 2032
Table 11: North America Cell Lysis & Disruption Market Value (US$ Bn),By Technique, 2017 – 2021
Table 12: North America Cell Lysis & Disruption Market Value (US$ Bn),By Technique, 2022 – 2032
Table 13: North America Cell Lysis & Disruption Market Value (US$ Bn), By Product Type, 2017 – 2021
Table 14: North America Cell Lysis & Disruption Market Value (US$ Bn), By Product Type, 2022 – 2032
Table 15: North America Cell Lysis & Disruption Market Value (US$ Bn), By Cell Type, 2017 – 2021
Table 16: North America Cell Lysis & Disruption Market Value (US$ Bn), By Cell Type, 2022 – 2032
Table 17: North America Cell Lysis & Disruption Market Value (US$ Bn), By Application, 2017 – 2021
Table 18: North America Cell Lysis & Disruption Market Value (US$ Bn), By Application, 2022 – 2032
Table 19: North America Cell Lysis & Disruption Market, By Country, 2017 – 2021
Table 20: North America Cell Lysis & Disruption Market, By Country, 2022 – 2032
Table 21: Latin America Cell Lysis & Disruption Market Value (US$ Bn),By Technique, 2017 – 2021
Table 22: Latin America Cell Lysis & Disruption Market Value (US$ Bn),By Technique, 2022 – 2032
Table 23: Latin America Cell Lysis & Disruption Market Value (US$ Bn), By Product Type, 2017 – 2021
Table 24: Latin America Cell Lysis & Disruption Market Value (US$ Bn), By Product Type, 2022 – 2032
Table 25: Latin America Cell Lysis & Disruption Market Value (US$ Bn), By Cell Type, 2017 – 2021
Table 26: Latin America Cell Lysis & Disruption Market Value (US$ Bn), By Cell Type, 2022 – 2032
Table 27: Latin America Cell Lysis & Disruption Market Value (US$ Bn), By Application, 2017 – 2021
Table 28: Latin America Cell Lysis & Disruption Market Value (US$ Bn), By Application, 2022 – 2032
Table 29: Latin America Cell Lysis & Disruption Market, By Country, 2017 – 2021
Table 30: Latin America Cell Lysis & Disruption Market, By Country, 2022 – 2032
Table 31: Europe Cell Lysis & Disruption Market Value (US$ Bn),By Technique, 2017 – 2021
Table 32: Europe Cell Lysis & Disruption Market Value (US$ Bn),By Technique, 2022 – 2032
Table 33: Europe Cell Lysis & Disruption Market Value (US$ Bn), By Product Type, 2017 – 2021
Table 34: Europe Cell Lysis & Disruption Market Value (US$ Bn), By Product Type, 2022 – 2032
Table 35: Europe Cell Lysis & Disruption Market Value (US$ Bn), By Cell Type, 2017 – 2021
Table 36: Europe Cell Lysis & Disruption Market Value (US$ Bn), By Cell Type, 2022 – 2032
Table 37: Europe Cell Lysis & Disruption Market Value (US$ Bn), By Application, 2017 – 2021
Table 38: Europe Cell Lysis & Disruption Market Value (US$ Bn), By Application, 2022 – 2032
Table 39: Europe Cell Lysis & Disruption Market, By Country, 2017 – 2021
Table 40: Europe Cell Lysis & Disruption Market, By Country, 2022 – 2032
Table 41: APAC Cell Lysis & Disruption Market Value (US$ Bn),By Technique, 2017 – 2021
Table 42: APAC Cell Lysis & Disruption Market Value (US$ Bn),By Technique, 2022 – 2032
Table 43: APAC Cell Lysis & Disruption Market Value (US$ Bn), By Product Type, 2017 – 2021
Table 44: APAC Cell Lysis & Disruption Market Value (US$ Bn), By Product Type, 2022 – 2032
Table 45: APAC Cell Lysis & Disruption Market Value (US$ Bn), By Cell Type, 2017 – 2021
Table 46: APAC Cell Lysis & Disruption Market Value (US$ Bn), By Cell Type, 2022 – 2032
Table 47: APAC Cell Lysis & Disruption Market Value (US$ Bn), By Application, 2017 – 2021
Table 48: APAC Cell Lysis & Disruption Market Value (US$ Bn), By Application, 2022 – 2032
Table 49: APAC Cell Lysis & Disruption Market, By Country, 2017 – 2021
Table 50: APAC Cell Lysis & Disruption Market, By Country, 2022 – 2032
Table 51: MEA Cell Lysis & Disruption Market Value (US$ Bn),By Technique, 2017 – 2021
Table 52: MEA Cell Lysis & Disruption Market Value (US$ Bn),By Technique, 2022 – 2032
Table 53: MEA Cell Lysis & Disruption Market Value (US$ Bn), By Product Type, 2017 – 2021
Table 54: MEA Cell Lysis & Disruption Market Value (US$ Bn), By Product Type, 2022 – 2032
Table 55: MEA Cell Lysis & Disruption Market Value (US$ Bn), By Cell Type, 2017 – 2021
Table 56: MEA Cell Lysis & Disruption Market Value (US$ Bn), By Cell Type, 2022 – 2032
Table 57: MEA Cell Lysis & Disruption Market Value (US$ Bn), By Application, 2017 – 2021
Table 58: MEA Cell Lysis & Disruption Market Value (US$ Bn), By Application, 2022 – 2032
Table 59: MEA Cell Lysis & Disruption Market, By Country, 2017 – 2021
Table 60: MEA Cell Lysis & Disruption Market, By Country, 2022 – 2032
List of Figures
Figure 1: Global Cell Lysis & Disruption Market Value (US$ Bn) and Year-on-Year Growth, 2017-2032
Figure 2: Global Cell Lysis & Disruption Market Absolute $ Historical Gain (2017 - 2021) and Opportunity (2022 – 2032), US$ Bn
Figure 3: Global Cell Lysis & Disruption Market Share, By Technique, 2022 & 2032
Figure 4: Global Cell Lysis & Disruption Market Y-o-Y Growth Projections, By Technique – 2022-2032
Figure 5: Global Cell Lysis & Disruption Market Attractiveness Index, By Technique – 2022-2032
Figure 6: Global Cell Lysis & Disruption Market Share, By Product Type, 2022 & 2032
Figure 7: Global Cell Lysis & Disruption Market Y-o-Y Growth Projections, By Product Type – 2022-2032
Figure 8: Global Cell Lysis & Disruption Market Attractiveness Index, By Product Type – 2022-2032
Figure 9: Global Cell Lysis & Disruption Market Share, By Application, 2022 & 2032
Figure 10: Global Cell Lysis & Disruption Market Y-o-Y Growth Projections, By Application – 2022-2032
Figure 11: Global Cell Lysis & Disruption Market Attractiveness Index, By Application – 2022-2032
Figure 12: Global Cell Lysis & Disruption Market Share, By Cell Type, 2022 & 2032
Figure 13: Global Cell Lysis & Disruption Market Y-o-Y Growth Projections, By Cell Type – 2022-2032
Figure 14: Global Cell Lysis & Disruption Market Attractiveness Index, By Cell Type – 2022-2032
Figure 15: Global Cell Lysis & Disruption Market Share, By Region, 2022 & 2032
Figure 16: Global Cell Lysis & Disruption Market Y-o-Y Growth Projections, By Region – 2022-2032
Figure 17: Global Cell Lysis & Disruption Market Attractiveness Index, By Region – 2022-2032
Figure 18: North America Cell Lysis & Disruption Market Value (US$ Bn) and Year-on-Year Growth, 2017-2032
Figure 19: North America Cell Lysis & Disruption Market Absolute $ Opportunity Historical (2017 - 2021) and Forecast Period (2022 – 2032), US$ Bn
Figure 20: North America Cell Lysis & Disruption Market Share, By Technique, 2022 & 2032
Figure 21: North America Cell Lysis & Disruption Market Y-o-Y Growth Projections, By Technique – 2022-2032
Figure 22: North America Cell Lysis & Disruption Market Attractiveness Index, By Technique – 2022-2032
Figure 23: North America Cell Lysis & Disruption Market Share, By Product Type, 2022 & 2032
Figure 24: North America Cell Lysis & Disruption Market Y-o-Y Growth Projections, By Product Type – 2022-2032
Figure 25: North America Cell Lysis & Disruption Market Attractiveness Index, By Product Type – 2022-2032
Figure 26: North America Cell Lysis & Disruption Market Share, By Application, 2022 & 2032
Figure 27: North America Cell Lysis & Disruption Market Y-o-Y Growth Projections, By Application – 2022-2032
Figure 28: North America Cell Lysis & Disruption Market Attractiveness Index, By Application – 2022-2032
Figure 29: North America Cell Lysis & Disruption Market Share, By Cell Type, 2022 & 2032
Figure 30: North America Cell Lysis & Disruption Market Y-o-Y Growth Projections, By Cell Type – 2022-2032
Figure 31: North America Cell Lysis & Disruption Market Attractiveness Index, By Cell Type – 2022-2032
Figure 32: North America Cell Lysis & Disruption Market Share, By Country, 2022 & 2032
Figure 33: North America Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 34: North America Market Attractiveness Index, By Country – 2022-2032
Figure 35: Latin America Cell Lysis & Disruption Market Value (US$ Bn) and Year-on-Year Growth, 2017-2032
Figure 36: Latin America Cell Lysis & Disruption Market Absolute $ Opportunity Historical (2017 - 2021) and Forecast Period (2022 – 2032), US$ Bn
Figure 37: Latin America Cell Lysis & Disruption Market Share, By Technique, 2022 & 2032
Figure 38: Latin America Cell Lysis & Disruption Market Y-o-Y Growth Projections, By Technique – 2022-2032
Figure 39: Latin America Cell Lysis & Disruption Market Attractiveness Index, By Technique – 2022-2032
Figure 40: Latin America Cell Lysis & Disruption Market Share, By Product Type, 2022 & 2032
Figure 41: Latin America Cell Lysis & Disruption Market Y-o-Y Growth Projections, By Product Type – 2022-2032
Figure 42: Latin America Cell Lysis & Disruption Market Attractiveness Index, By Product Type – 2022-2032
Figure 43: Latin America Cell Lysis & Disruption Market Share, By Application, 2022 & 2032
Figure 44: Latin America Cell Lysis & Disruption Market Y-o-Y Growth Projections, By Application – 2022-2032
Figure 45: Latin America Cell Lysis & Disruption Market Attractiveness Index, By Application – 2022-2032
Figure 46: Latin America Cell Lysis & Disruption Market Share, By Cell Type, 2022 & 2032
Figure 47: Latin America Cell Lysis & Disruption Market Y-o-Y Growth Projections, By Cell Type – 2022-2032
Figure 48: Latin America Cell Lysis & Disruption Market Attractiveness Index, By Cell Type – 2022-2032
Figure 49: Latin America Cell Lysis & Disruption Market Share, By Country, 2022 & 2032
Figure 50: Latin America Cell Lysis & Disruption Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 51: Latin America Cell Lysis & Disruption Market Attractiveness Index, By Country – 2022-2032
Figure 52: Europe Cell Lysis & Disruption Market Value (US$ Bn) and Year-on-Year Growth, 2017-2032
Figure 53: Europe Cell Lysis & Disruption Market Absolute $ Opportunity Historical (2017 - 2021) and Forecast Period (2022 – 2032), US$ Bn
Figure 54: Europe Cell Lysis & Disruption Market Share, By Technique, 2022 & 2032
Figure 55: Europe Cell Lysis & Disruption Market Y-o-Y Growth Projections, By Technique – 2022-2032
Figure 56: Europe Cell Lysis & Disruption Market Attractiveness Index, By Technique – 2022-2032
Figure 57: Europe Cell Lysis & Disruption Market Share, By Product Type, 2022 & 2032
Figure 58: Europe Cell Lysis & Disruption Market Y-o-Y Growth Projections, By Product Type – 2022-2032
Figure 59: Europe Cell Lysis & Disruption Market Attractiveness Index, By Product Type – 2022-2032
Figure 60: Europe Cell Lysis & Disruption Market Share, By Application, 2022 & 2032
Figure 61: Europe Cell Lysis & Disruption Market Y-o-Y Growth Projections, By Application – 2022-2032
Figure 62: Europe Cell Lysis & Disruption Market Attractiveness Index, By Application – 2022-2032
Figure 63: Europe Cell Lysis & Disruption Market Share, By Cell Type, 2022 & 2032
Figure 64: Europe Cell Lysis & Disruption Market Y-o-Y Growth Projections, By Cell Type – 2022-2032
Figure 65: Europe Cell Lysis & Disruption Market Attractiveness Index, By Cell Type – 2022-2032
Figure 66: Europe Cell Lysis & Disruption Market Share, By Country, 2022 & 2032
Figure 67: Europe Cell Lysis & Disruption Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 68: Europe Cell Lysis & Disruption Market Attractiveness Index, By Country – 2022-2032
Figure 69: MEA Cell Lysis & Disruption Market Value (US$ Bn) and Year-on-Year Growth, 2017-2032
Figure 70: MEA Cell Lysis & Disruption Market Absolute $ Opportunity Historical (2017 - 2021) and Forecast Period (2022 – 2032), US$ Bn
Figure 71: MEA Cell Lysis & Disruption Market Share, By Technique, 2022 & 2032
Figure 72: MEA Cell Lysis & Disruption Market Y-o-Y Growth Projections, By Technique – 2022-2032
Figure 73: MEA Cell Lysis & Disruption Market Attractiveness Index, By Technique – 2022-2032
Figure 74: MEA Cell Lysis & Disruption Market Share, By Product Type, 2022 & 2032
Figure 75: MEA Cell Lysis & Disruption Market Y-o-Y Growth Projections, By Product Type – 2022-2032
Figure 76: MEA Cell Lysis & Disruption Market Attractiveness Index, By Product Type – 2022-2032
Figure 77: MEA Cell Lysis & Disruption Market Share, By Application, 2022 & 2032
Figure 78: MEA Cell Lysis & Disruption Market Y-o-Y Growth Projections, By Application – 2022-2032
Figure 79: MEA Cell Lysis & Disruption Market Attractiveness Index, By Application – 2022-2032
Figure 80: MEA Cell Lysis & Disruption Market Share, By Cell Type, 2022 & 2032
Figure 81: MEA Cell Lysis & Disruption Market Y-o-Y Growth Projections, By Cell Type – 2022-2032
Figure 82: MEA Cell Lysis & Disruption Market Attractiveness Index, By Cell Type – 2022-2032
Figure 83: MEA Cell Lysis & Disruption Market Share, By Country, 2022 & 2032
Figure 84: MEA Cell Lysis & Disruption Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 85: MEA Cell Lysis & Disruption Market Attractiveness Index, By Country – 2022-2032
Figure 86: APAC Cell Lysis & Disruption Market Value (US$ Bn) and Year-on-Year Growth, 2017-2032
Figure 87: APAC Cell Lysis & Disruption Market Absolute $ Opportunity Historical (2017 - 2021) and Forecast Period (2022 – 2032), US$ Bn
Figure 88: APAC Cell Lysis & Disruption Market Share, By Technique, 2022 & 2032
Figure 89: APAC Cell Lysis & Disruption Market Y-o-Y Growth Projections, By Technique – 2022-2032
Figure 90: APAC Cell Lysis & Disruption Market Attractiveness Index, By Technique – 2022-2032
Figure 91: APAC Cell Lysis & Disruption Market Share, By Product Type, 2022 & 2032
Figure 92: APAC Cell Lysis & Disruption Market Y-o-Y Growth Projections, By Product Type – 2022-2032
Figure 93: APAC Cell Lysis & Disruption Market Attractiveness Index, By Product Type – 2022-2032
Figure 94: APAC Cell Lysis & Disruption Market Share, By Application, 2022 & 2032
Figure 95: APAC Cell Lysis & Disruption Market Y-o-Y Growth Projections, By Application – 2022-2032
Figure 96: APAC Cell Lysis & Disruption Market Attractiveness Index, By Application – 2022-2032
Figure 97: APAC Cell Lysis & Disruption Market Share, By Cell Type, 2022 & 2032
Figure 98: APAC Cell Lysis & Disruption Market Y-o-Y Growth Projections, By Cell Type – 2022-2032
Figure 99: APAC Cell Lysis & Disruption Market Attractiveness Index, By Cell Type – 2022-2032
Figure 100: APAC Cell Lysis & Disruption Market Share, By Country, 2022 & 2032
Figure 101: APAC Cell Lysis & Disruption Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 102: APAC Cell Lysis & Disruption Market Attractiveness Index, By Country – 2022-2032
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Cell Lysis & Disruption Market
*86 figures and 60 tables includes